Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 1,095,855 | 229,475 | 219,177 | 795,084 | 483,684 | 2,823,275 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 0 | |||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | |||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | |||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | |||||
| 6 | Total. Add lines 1 through 5 | 1,095,855 | 229,475 | 219,177 | 795,084 | 483,684 | 2,823,275 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | |||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | |||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 2,823,275 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 1,095,855 | 229,475 | 219,177 | 795,084 | 483,684 | 2,823,275 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | -1,075 | 691 | -384 | |||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | 0 | |||||
| c | Add lines 10a and 10b. | -1,075 | 691 | -384 | |||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | |||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 0 | |||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 1,095,855 | 229,475 | 219,177 | 794,009 | 484,375 | 2,822,891 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 23017517 |
| Software Version: | 2023v5.1 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part VI, Section B, Line 11b | LINE 11B EXPLANATION - A COPY OF THE FORM 990 WAS PROVIDED TO THE EXECUTIVE DIRECTOR PRIOR TO FILING FOR HIS AND/OR THE BOARD'S REVIEW. UPON APPROVAL THE FORM WILL BE FILED. |
| Form 990, Part VI, Section C, Line 18 | Other information available upon request. |
| Form 990, Part VI, Section C, Line 19 | Other information available upon request. |
| Form 990, Part III, Line 4a | Form 990, Part III, Line 4aProgram Service Accomplishments In 2023 the organization operated the following programs. Research - Several unique research initiatives and partnerships are underway or in development:American Glaucoma Society MAPS Grant 2023 marks the 9th year CGF has funded the AGS MAPS Program. This program supports early career glaucoma specialists and scientists by providing tools and resources to further their careers as potential leaders in the science, research and the specialty of glaucoma care.Catalyst for the Cure (CFC) Vision Restoration Initiative - 2023 marks the 4th year CGF has funded a grant to this important program, the goals of CFC are: 1.To develop a strategy for optic nerve cell transplantation2.To develop neuroprotective therapies for glaucoma. In the past year, there has been significant progress on both fronts.Global Outreach - CGF sponsors Medical Mission Trips to provide care for patients in underserved countries:Cure Glaucoma Foundations Train the Trainer, glaucoma drainage device (GDD) implant, Mission Outreach Program - Many glaucoma patients in countries in Africa are greatly underserved. This program is designed to teach qualified ophthalmologists in those countries how to implant the drain and, within 18 months, they will in turn train another physician in their resident country how to do the same. By this process CGF, in partnership with New World Medical, will greatly expand access to effective glaucoma therapy for many people. Our partners who have made this program possible are: New World Medical, the Eye Foundation Hospital, Lagos, Nigeria, the City Eye Hospital, Nairobi, Kenya, the American Academy of Ophthalmology and Cure Glaucoma Foundation and its supportive donors.In 2023, Cure Glaucoma Sponsored the following mission trips:Nigeria Glaucoma Drainage Device Training Class, March 2023In March 2023, Dr. Ogunro and her team from the Eye Foundation Hospital in Nigeria, completed their first in-Country GDD training program for (5) Nigerian physicians. This is in keeping with the Train the Trainer program goals of a self-expanding program where recipients of previous GDD training efforts become the next generation of trainers.We would like to congratulate Dr. Ogunro and her team on this great accomplishment! To support Dr. Ogunro CGF provided medical supplies thanks to the generosity of our medical supply partners. The synergy of partnerships between CGF, skilled physicians like Dr. Ogunro and our medical supply partners results in training of ophthalmologists in advanced glaucoma surgeries all over the world who can better care for their patients.Congratulations to the following physicians who are registered as qualified to participate in the GDD program:Dr Adanma Chinyele Ezenwa - (Nnamdi Azikiwe University Teaching Hospital Nnewi)Dr Genevieve Onochie-Olubobokun - (St Edmund's Eye Clinic and Hospital Lagos)Dr Aisha Kalmbe - (Asokoro District Hospital Abuja)Dr Abdullahi Sadiq Mohammed - (National Eye Centre Kaduna)Dr Adaora Okudo - (Asokoro District Hospital Abuja)A special thanks to New World Medical whose ongoing support and commitment to this important program make it possible to achieve these important goals.Bali, Indonesia 15-17 March 2023In March, the Cure Glaucoma Foundation, in collaboration with the Indonesian Glaucoma Society and the Udayana University/Mangusada Hospital, organized a 3-day global outreach program in Bali, Indonesia. On site, my colleagues Lola Idowu, MD, and Ramya Swamy, MD, and I (Dr. Tosin Smith) executed the MIGS Didactic Course and Wet Lab Conference, during which 36 Indonesian surgeons received training in various glaucoma procedures, with a focus on MIGS. Attendees participated in live and virtual lectures delivered by 12 experts in glaucoma. They also engaged in live surgical training and wet lab sessions, resulting in a total of 25 surgeries performed during the event. For me, the joy of delivering this program stems from witnessing its profound impact on physician education and patient care, both within Indonesia and across the globe. The programs impact extends beyond the immediate patient care provided; it also involves bringing local surgeons up to date with the latest glaucoma procedures and offering ongoing support as they become proficient in newer techniques. Further, the program shed light on existing deficiencies within the health care system. Notably, it revealed that selective laser trabeculoplasty has been underutilized due to limited exposure and a lack of equipment. The Cure Glaucoma Foundation is collaborating with Dr. Swamy to return to Bali and introduce the procedure. Another observation I made in Bali is a need to discuss ways to improve postoperative management of trabeculectomy. To address this, I plan to host an observership at my practice in Dallas for a glaucoma specialist from Udayana University. This will allow the physician to observe postoperative treatment plans for patients over the course of weeks and months, and they will then return to Udayana University to share this knowledge with others.A total of 25 MIGS surgeries were performed, and 36 physicians and medical staff personnel were trained.Access to Care - The purpose of the Access to Care Project (ACP) is to take a proactive approach to reduce the burden of blindness. ACP is designed to address the unmet needs of persons affected by glaucoma with limited financial resources. Patient care provided will include eye exams, surgical, and postoperative clinical care necessary to prevent disease progression and blindness.South Dallas Glaucoma Services Clinic 2023The 2019 Dallas County Needs Assessment highlighted significant health and access disparities, particularly evident in Zip codes 75210, 75216, 75217, and 75241. These areas, predominantly inhabited by Black and Hispanic residents, face heightened vulnerability to glaucoma, the leading cause of blindness among African Americans. Alarmingly, half of those affected are unaware of their condition. Furthermore, glaucoma manifests more aggressively, earlier, and with greater severity in African American populations, posing a significant public health challenge.It has long been the dream of our physician founders, from Glaucoma Associates of Texas (GAT), to extend their reach to the South Dallas community, offering essential glaucoma care. This collaborative program is distinctive in its provision of low-cost glaucoma services to disadvantaged individuals in the Dallas-Fort Worth metroplex, filling a crucial gap that no other nonprofit currently addresses.Our South Dallas Glaucoma Services Clinic serves as a specialized referral center for glaucoma patients identified by organizations like the Center for Vision Health. Patients, regardless of financial status, receive treatment from leading glaucoma specialists, preventing vision loss and disability through access to care and education.In 2023, CGF collaborated with the Society of St. Vincent de Paul Pharmacy of North Texas, providing them with a $7,000 grant to expand their formulary with glaucoma medications. This initiative aims to provide affordable access to essential medications for patients at the South Dallas clinic, fostering medication adherence and ensuring comprehensive care for underserved individuals.In 2023 our South Dallas Glaucoma Services Clinic served 65 patients. |
| FORM 990, PART VI SECTION B, LINE 11B: | LINE 11B EXPLANATION - A COPY OF THE FORM 990 WAS PROVIDED TO THE EXECUTIVE DIRECTOR PRIOR TO FILING FOR HIS AND/OR THE BOARD'S REVIEW. UPON APPROVAL THE FORM WILL BE FILED. |
| Software ID: | 23017517 |
| Software Version: | 2023v5.1 |